Tony Todd American actor

-

 

At the age of 69, Tony Todd, the legendary actor most recognized for his terrifying performance in Candyman, passed suddenly. Jeffrey Goldberg, his manager, confirmed his passing and recalled Todd as a wonderful, affable man. 
In addition to Candyman, Todd received praise for his parts in the Final Destination television series, The Rock, The Crow, and other Star Trek appearances. His iconic voice was used for a variety of roles, such as Venom in the computer game Spider-Man 2 and Zoom in That Flash.

At the age of 69, Tony Todd, the celebrated actor most remembered for playing the title character in the "Candyman" horror series, died on November 6, 2024. Jeffrey Goldberg, his longtime manager, confirmed his death, but the cause has not been made public. Over 240 film and television credits were part of Todd's illustrious career.
 In addition to "Candyman," he was well-known for his parts in the Vietnam War movie Platoon and Kurn, Worf's brother, among other roles in the Star Trek world. In addition, he voiced characters in Transformers: 
Prime and Young Justice and made prominent cameos in Final Destination and The Young and the Restless. Apart from his involvement in movies, Todd had a close ties to the theater, frequently spending time on stage productions, which he attributed to helping him refine his skills. He compared his Candyman character to a "misunderstood gothic character searching for love" and saw him as a tragic figure.

Comments

Post a Comment

Popular posts from this blog

DeAndre Hopkins American american football wide receiver

-
Image
  DeAndre Hopkins is an American football wide receiver currently playing for the Tennessee Titans in the NFL. Known for his exceptional catching ability, precise route running, and strong hands, Hopkins has consistently been one of the league's top receivers. He was born on June 6, 1992, in Clemson, South Carolina, and played college football at Clemson University before being selected by the Houston Texans in the first round of the 2013 NFL Draft. Hopkins played for the Texans from 2013 to 2019, establishing himself as one of the most reliable and productive receivers in the NFL. In 2020, he was traded to the Arizona Cardinals, where he continued to perform at a high level before signing with the Tennessee Titans in 2023. Throughout his career, Hopkins has earned multiple Pro Bowl selections and All-Pro honors. Known for his nickname "Nuk," he has made numerous highlight-reel catches and is regarded as one of the best wide receivers of his generation. Pete Prisco's ...
Read more

Microsoft’s Majorana 1 chip carves new path for quantum computing

-
 Microsoft’s Majorana 1 chip carves new path for quantum computing Microsoft has recently unveiled the Majorana 1 chip, a groundbreaking advancement in quantum computing. This chip is notable for being the first to utilize a Topological Core architecture, which is designed to enable quantum computers to solve complex industrial-scale problems much faster than traditional systems.  Key Features of Majorana 1 - Topoconductor Material: The Majorana 1 chip leverages a new type of material known as a topoconductor, which allows for the observation and control of Majorana particles. This capability is crucial for creating more reliable and scalable qubits, the fundamental units of quantum computing[1][2][3]. - Scalability: Microsoft claims that this architecture can potentially fit up to one million qubits on a single chip, dramatically increasing computational power and efficiency. This level of scalability is essential for tackling significant challenges, such as breaking down mic...
Read more

eli lilly weight loss drug india

-
Image
 Eli Lilly has launched its weight-loss and type 2 diabetes medication, Mounjaro (tirzepatide), in India following approval from the Central Drugs Standard Control Organisation. This once-weekly injectable drug is available in single-dose vials, with the 2.5 mg vial priced at ₹3,500 and the 5 mg vial at ₹4,375. Mounjaro functions by activating hormone receptors that regulate blood sugar levels and appetite, aiding in weight management.  However, potential side effects include gastrointestinal issues, pancreatitis, hypoglycemia, and gallbladder problems. Individuals with specific health conditions should consult a doctor before use.  The introduction of Mounjaro is expected to intensify competition in India's obesity treatment market. Novo Nordisk plans to launch its weight-loss drug, Wegovy (semaglutide), by 2026 as its active ingredient is set to go off-patent in India. Additionally, Indian pharmaceutical companies like Sun Pharmaceutical, Biocon, Zydus Lifesciences, C...
Read more